Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

12.06USD
19 Jan 2018
Change (% chg)

$0.47 (+4.06%)
Prev Close
$11.59
Open
$11.58
Day's High
$12.30
Day's Low
$11.58
Volume
4,188
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.94

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.62 December 20 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 -- --
(2) OUTPERFORM 1 1 -- --
(3) HOLD 1 1 -- --
(4) UNDERPERFORM 0 0 -- --
(5) SELL 0 0 -- --
No Opinion 0 0 -- --
Mean Rating 1.75 1.75 -- --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 5.15 11.40 0.00 --
Earnings (per share)
Quarter Ending Mar-18 2 -1.62 -0.91 -2.34 --
Quarter Ending Jun-18 2 -1.48 -1.01 -1.94 --
Year Ending Dec-18 4 -5.59 -3.11 -7.75 --
LT Growth Rate (%) 1 0.60 0.60 0.60 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.20 0.60 0.40 203.51
Earnings (per share)
Quarter Ending Sep-17 -2.43 -36.02 33.59 -1,382.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 -- --
Quarter Ending Jun-18 0.00 0.00 0.00 -- --
Year Ending Dec-18 5.15 5.15 5.15 -- --
Earnings (per share)
Quarter Ending Mar-18 -1.62 -1.62 -1.62 -- --
Quarter Ending Jun-18 -1.48 -1.48 -1.48 -- --
Year Ending Dec-18 -5.59 -5.59 -5.59 -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0